Aquatic Capital Management LLC Eye Point Pharmaceuticals, Inc. Transaction History

Aquatic Capital Management LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$8.16 - $22.89 $147,696 - $414,309	-18,100 Reduced 44.8%	22,300 $194,000
Q1 2024 May 15, 2024	BUY	$19.93 - $29.71 $805,172 - $1.2 Million	40,400 New	40,400 $835,000
Q3 2022 Nov 14, 2022	BUY	$6.96 - $11.12 $25,752 - $41,144	3,700 Added 194.74%	5,600 $44,000
Q2 2022 Aug 15, 2022	BUY	$7.25 - $12.71 $13,775 - $24,149	1,900 New	1,900 $15,000

150

58M

177K

263K

Ticker EYPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 34,072,200
Market Cap $357M
Description
EyePoint Pharmaceuticals, Inc., a pharmaceutical company, develops and commercializes ophthalmic products for the treatment of eye diseases in the United States, China, and the United Kingdom. The company provides ILUVIEN, an injectable sustained-release micro-insert for treatment of diabetic macular edema; YUTIQ, a fluocinolone acetonide intrav...

Get notified when there are updates to the investment portfolio of Aquatic Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Aquatic Capital Management LLC with notifications on news.